PRODUCT INFORMATION

Novartis Pharmaceuticals Corporation is a leader in the field of transplantation. With its immunosuppressant therapies Neoral® (cyclosporine, USP) MODIFIED (see product safety information), Sandimmune® (cyclosporine, USP) (see product safety information), Simulect® (basiliximab) (see product safety information), and myfortic®(mycophenolic acid) (see product safety information), Novartis provides transplant recipients with therapeutic options that are intended to enhance quality of life and the long-term success of their organ transplant.

Choose one of the following links for more detailed product information.

		Neoral (cyclosporine, USP) MODIFIED
		Simulect (basiliximab)
		Sandimmune (cyclosporine, USP)
		myfortic (mycophenolic acid)

Medication Recognition Chart
A handout depicting the size, shape, and color of Neoral and Sandimmune, which your patients can consult to make sure that they receive what you prescribed.

To see myfortic tablets, click here.